Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
The Journal of Surgical Research|July 10, 2017
Pilot evaluation of the Computer-Based Assessment for Sampling Personal Characteristics testEdward S Shipper, Laura M Mazer, Sylvia Bereknyei Merrell, et al.
Kidney Medicine|March 26, 2026
Machine Learning Predictions for Assessing Hard-to-Place Deceased Donor KidneysGrace Guan, Joachim Studnia, Sanjit Neelam, et al.
Transplantation|August 16, 2023
Decreased Utilization Rate of Grafts for Liver Transplantation After Implementation of Acuity Circle-based AllocationYuki Bekki, Bryan Myers, Koji Tomiyama, et al.
JAMA Surgery|February 22, 2013
Kidney transplant chains amplify benefit of nondirected donorsMarc L Melcher, Jeffrey L Veale, Basit Javaid, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 22, 2024
Continuous Risk Score Predicts Waitlist and Post-transplant Outcomes in Hepatocellular Carcinoma Despite Exception ChangesMiho Akabane, John C McVey, Daniel J Firl, et al.
Archives of Surgery (Chicago, Ill. : 1960)|September 21, 2005
More than 500 consecutive laparoscopic donor nephrectomies without conversion or repeated surgeryMarc L Melcher, Jonathan T Carter, Andrew Posselt, et al.
Clinical Transplantation|October 9, 2023
The short and long-term prognostic influences of liver grafts with high bilirubin levels at the time of organ recoveryMiho Akabane, Yuki Bekki, Yuki Imaoka, et al.
AJR. American Journal of Roentgenology|February 23, 2018
Structured Reporting of Multiphasic CT for Hepatocellular Carcinoma: Effect on Staging and Suitability for TransplantPeter D Poullos, Joseph J Tseng, Marc L Melcher, et al.
BMJ Global Health|May 12, 2021
Assessing trauma care systems in low-income and middle-income countries: a systematic review and evidence synthesis mapping the Three Delays framework to injury health system assessmentsJohn Whitaker, Nollaig O'Donohoe, Max Denning, et al.
Lancet (London, England)|March 1, 2026
Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trialJulio Rosenstock, Daisuke Yabe, David Cox, et al.
Pageof 11